Stephen B. Brauerman

Wendy L. Divine

David E. Moore

Bindu Ann George Palapura

William F. Cavanaugh, Jr.

Natalie J. Morgan

Zhiqiang Liu

Kristina M. Hanson

Nicholas Halkowski

Mark A. Hayden

Sean M. Anderson

Chamyra L. Upshur

Emily Shingle

Basil Williams

Azurity Pharmaceuticals Inc

Arbor Pharmaceuticals LLC

Takeda Pharmaceutical Co Ltd

Annora Pharma PVT Ltd

Last Docket Entry Date

Total Docket Entries

ANDA filing sparks patent clash: Takeda accuses generic EDARBYCLOR® over hypertension drug claims for a `pH control agent` and `granulating separately` tech.

1:25-cv-01493 | Azurity Pharmaceuticals Inc v. Annora Pharma Pvt Ltd | Ex Parte

United States District of Delaware

Name	Ratings
Azurity Pharmaceuticals Inc	L3B
Takeda Pharmaceutical Co Ltd	L5A
Arbor Pharmaceuticals LLC	---- --

Name	Ratings
Wilson Sonsini Goodrich & Rosati	L5A
Wendy L. Divine	L5A
Kristina M. Hanson	L5A
Natalie J. Morgan	L5B
Mark A. Hayden	L4B
Nicholas Halkowski	---- --
Sean M. Anderson	---- --
Emily Shingle	---- --
Potter Anderson & Corroon LLPLocal	L5A
David E. Moore	L5A
Bindu Ann George Palapura	L5A
Chamyra L. Upshur	---- --
Patterson Belknap Webb & Tyler LLP	L3B
William F. Cavanaugh, Jr.	L5A
Zhiqiang Liu	L5B
Basil Williams	---- --

Name	Ratings
Bayard PA	L1D
Stephen B. Brauerman	---- --

1:25-cv-01493

Azurity Pharma Inc v. Annora Pharma Pvt Ltd